Mark B. Effron
Impact in
-
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Atrial Fibrillation Management and Outcomes
- Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Antiplatelet Therapy and Cardiovascular Diseases 65
- Acute Myocardial Infarction Research 33
- Atrial Fibrillation Management and Outcomes 10
- Surgery 28
- Coronary Interventions and Diagnostics 17
- Lipoproteins and Cardiovascular Health 9
- Heparin-Induced Thrombocytopenia and Thrombosis 4
- Co-authors
- Myron L. Weisfeldt (4 shared papers)Peter R. Freund (2 shared papers)W. Lowell Maughan (1 shared paper)Eric J. Topol (7 shared papers)Tracy Y. Wang (21 shared papers)Marjorie E. Zettler (22 shared papers)Eric David Peterson (20 shared papers)Dominick Joseph Angiolillo (11 shared papers)
- Journals
- Journal of the American College of Cardiology (21 papers)Circulation (17 papers)American Heart Journal (12 papers)Journal of the American Heart Association (8 papers)Catheterization and Cardiovascular Interventions (8 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Mark B. Effron
134 papers receiving 4.8k citations
Mark B. Effron's Hit Papers
Peers
Comparison fields: 5 of 117
- Cardiology and Cardiovascular Medicine 3.2k
- Internal Medicine 469
- Emergency Medicine 452
- Surgery 1.5k
- Family Practice 56
Countries citing papers authored by Mark B. Effron
This map shows the geographic impact of Mark B. Effron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark B. Effron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark B. Effron more than expected).
Fields of papers citing papers by Mark B. Effron
This network shows the impact of papers produced by Mark B. Effron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark B. Effron. The network helps show where Mark B. Effron may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark B. Effron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 141 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Randomized, Placebo-Controlled Trial of Platelet Glycoprotein IIb/IIIa Blockade With Primary Angioplasty for Acute Myocardial Infarction Hit paper breakdown → | 1998 | 547 |
| 2 | Facilitated PCI in Patients with ST-Elevation Myocardial Infarction Hit paper breakdown → | 2008 | 496 |
| 3 | Mechanisms of blood flow during cardiopulmonary resuscitation. Hit paper breakdown → | 1980 | 344 |
| 4 | 2007 | 300 | |
| 5 | Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease Hit paper breakdown → | 2021 | 200 |
| 6 | 2011 | 164 | |
| 7 | 2010 | 148 | |
| 8 | The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events | 1996 | 135 |
| 9 | 2003 | 120 | |
| 10 | 2001 | 116 | |
| 11 | 1988 | 108 | |
| 12 | 2009 | 93 | |
| 13 | 1996 | 89 | |
| 14 | 2013 | 80 | |
| 15 | 1987 | 79 | |
| 16 | 2000 | 78 | |
| 17 | 2014 | 77 | |
| 18 | 2009 | 74 | |
| 19 | 2015 | 73 | |
| 20 | 2023 | 71 |
About Mark B. Effron
Mark B. Effron is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Internal Medicine, Endocrinology, Diabetes and Metabolism and Family Practice, having authored 141 papers that have together received 5.3k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (65 papers), Acute Myocardial Infarction Research (33 papers), Coronary Interventions and Diagnostics (17 papers), Atrial Fibrillation Management and Outcomes (10 papers), Lipoproteins and Cardiovascular Health (9 papers), Venous Thromboembolism Diagnosis and Management (6 papers), COVID-19 Clinical Research Studies (4 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (3.2k citations), Internal Medicine (469 citations), Emergency Medicine (452 citations), Surgery (1.5k citations) and Family Practice (56 citations). Mark B. Effron has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Myron L. Weisfeldt, Peter R. Freund, W. Lowell Maughan, Eric J. Topol, Tracy Y. Wang, Marjorie E. Zettler, Eric David Peterson, Dominick Joseph Angiolillo, Barry S. George and Brian Baker. Their work appears in journals such as Journal of the American College of Cardiology, Circulation, American Heart Journal, Journal of the American Heart Association and Catheterization and Cardiovascular Interventions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.